These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 23258240)

  • 1. [Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation].
    Andreozzi P; Viscogliosi G; Colella F; Subic M; Cipriani E; Marigliano B; Verrusio W; Servello A; Ettorre E; Marigliano V
    Recenti Prog Med; 2012 Dec; 103(12):570-4. PubMed ID: 23258240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.
    Sinn DH; Gwak GY; Park HN; Kim JE; Min YW; Kim KM; Kim YJ; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Am J Gastroenterol; 2012 Apr; 107(4):561-7. PubMed ID: 22108448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease.
    Bajaj S; Nigam P; Luthra A; Pandey RM; Kondal D; Bhatt SP; Wasir JS; Misra A
    Indian J Med Res; 2009 Mar; 129(3):285-92. PubMed ID: 19491421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
    Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
    Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease.
    Petta S; Amato MC; Di Marco V; Cammà C; Pizzolanti G; Barcellona MR; Cabibi D; Galluzzo A; Sinagra D; Giordano C; Craxì A
    Aliment Pharmacol Ther; 2012 Jan; 35(2):238-47. PubMed ID: 22117531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome.
    Mikolasevic I; Milic S; Orlic L; Stimac D; Franjic N; Targher G
    J Diabetes Complications; 2016; 30(7):1347-53. PubMed ID: 27324703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cut-off values of waist circumference to predict metabolic syndrome in obese adolescents.
    Masquio DC; Ganen Ade P; Campos RM; Sanches Pde L; Corgosinho FC; Caranti D; Tock L; de Mello MT; Tufik S; Dâmaso AR
    Nutr Hosp; 2015 Apr; 31(4):1540-50. PubMed ID: 25795939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study.
    Motamed N; Miresmail SJ; Rabiee B; Keyvani H; Farahani B; Maadi M; Zamani F
    J Diabetes Complications; 2016 Mar; 30(2):269-74. PubMed ID: 26718936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
    Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
    J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between non-alcoholic fatty liver disease and liver function/injury markers with metabolic syndrome components in class III obese individuals.
    Chaves GV; Souza DS; Pereira SE; Saboya CJ; Peres WA
    Rev Assoc Med Bras (1992); 2012; 58(3):288-93. PubMed ID: 22735219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women.
    Bruno Ade S; Rodrigues MH; Alvares MC; Nahas-Neto J; Nahas EA
    Climacteric; 2014 Aug; 17(4):465-71. PubMed ID: 24517420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
    Bondini S; Kallman J; Wheeler A; Prakash S; Gramlich T; Jondle DM; Younossi ZM
    Liver Int; 2007 Jun; 27(5):607-11. PubMed ID: 17498244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease.
    Fujii H; Imajo K; Yoneda M; Nakahara T; Hyogo H; Takahashi H; Hara T; Tanaka S; Sumida Y; Eguchi Y; Chayama K; Nakajima A; Nishimoto N; Kawada N;
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1390-1395. PubMed ID: 30600551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients.
    Targher G; Bertolini L; Padovani R; Poli F; Scala L; Zenari L; Zoppini G; Falezza G
    J Endocrinol Invest; 2006 Jan; 29(1):55-60. PubMed ID: 16553034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.